Founded in 1885 and family-owned ever since, Boehringer Ingelheim takes a long-term, sustainable perspective. More than 53,000 employees serve over 130 markets in the two business units Human Pharma ...

While you may think of healthcare as only covering human health, animal and pet health is also a growing sector. Click to ...

Program, a national youth initiative of the Canadian Cattle Association (CCA), has announced its 16 finalists for ...

The U.S. Food and Drug Administration approved Astellas' therapy to treat a type of gastric cancer, the health ... Pharma and German partner Boehringer Ingelheim have won the U.S. Food and Drug ...

The global poultry diagnostics market is on the verge of remarkable expansion, with analysts forecasting a robust Compound Annual Growth Rate (CAGR) of 10.5% over the next decade. Valued at USD 590 ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

The Global Veterinary Antiseptic Market was valued at approximately USD 3.47 billion in 2023 and is anticipated to grow to at a compound annual growth rate (CAGR) of 7.2% during the forecast period ...

The global ruminant vaccines market, valued at USD 3.51 billion in 2023, is projected to grow significantly at a compound annual growth rate (CAGR) of 6.95% from 2024 to 2032. Read the Market Summary ...

The global veterinary biologics market is on a robust growth trajectory, with its valuation expected to reach USD 13,140.6 ...

Merck Animal Health, Ceva, Zoetis, and Boehringer Ingelheim GmbH are a few of Europe’s key players in the Global Swine ...